BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15104769)

  • 1. Timing of angiography and revascularization in acute coronary syndromes: an analysis of the TACTICS-TIMI-18 trial.
    McCullough PA; Gibson CM; Dibattiste PM; Demopoulos LA; Murphy SA; Weintraub WS; Neumann FJ; Khanal S; Cannon CP;
    J Interv Cardiol; 2004 Apr; 17(2):81-6. PubMed ID: 15104769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial.
    Sabatine MS; Morrow DA; Giugliano RP; Murphy SA; Demopoulos LA; DiBattiste PM; Weintraub WS; McCabe CH; Antman EM; Cannon CP; Braunwald E
    Circulation; 2004 Feb; 109(7):874-80. PubMed ID: 14757697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Greater benefit of early invasive strategy for unstable angina and non-ST elevation myocardial infarction in United States compared with non-United States patients: a TACTICS-TIMI 18 substudy.
    Herrmann HC; Murphy SA; Dibattiste PM; Delucca PT; Demopoulos LA; Gibson CM; Cannon CP
    Crit Pathw Cardiol; 2004 Jun; 3(2):95-100. PubMed ID: 18340148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.
    Tricoci P; Lokhnygina Y; Berdan LG; Steinhubl SR; Gulba DC; White HD; Kleiman NS; Aylward PE; Langer A; Califf RM; Ferguson JJ; Antman EM; Newby LK; Harrington RA; Goodman SG; Mahaffey KW
    Circulation; 2007 Dec; 116(23):2669-77. PubMed ID: 18025532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diverging associations of an intended early invasive strategy compared with actual revascularization, and outcome in patients with non-ST-segment elevation acute coronary syndrome: the problem of treatment selection bias.
    Hirsch A; Windhausen F; Tijssen JG; Oude Ophuis AJ; van der Giessen WJ; van der Zee PM; Cornel JH; Verheugt FW; de Winter RJ;
    Eur Heart J; 2009 Mar; 30(6):645-54. PubMed ID: 18824461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing of angiography with a routine invasive strategy and long-term outcomes in non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II (Fragmin and Fast Revascularization During Instability in Coronary Artery Disease), ICTUS (Invasive Versus Conservative Treatment in Unstable Coronary Syndromes), and RITA-3 (Intervention Versus Conservative Treatment Strategy in Patients With Unstable Angina or Non-ST Elevation Myocardial Infarction) Trials.
    Damman P; van Geloven N; Wallentin L; Lagerqvist B; Fox KA; Clayton T; Pocock SJ; Hirsch A; Windhausen F; Tijssen JG; de Winter RJ
    JACC Cardiovasc Interv; 2012 Feb; 5(2):191-9. PubMed ID: 22361604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How should patients with unstable angina and non-ST-segment elevation myocardial infarction be managed? A meta-analysis of randomized trials.
    Choudhry NK; Singh JM; Barolet A; Tomlinson GA; Detsky AS
    Am J Med; 2005 May; 118(5):465-74. PubMed ID: 15866246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early cardiac catheterization is associated with lower mortality only among high-risk patients with ST- and non-ST-elevation acute coronary syndromes: observations from the OPUS-TIMI 16 trial.
    Cantor WJ; Goodman SG; Cannon CP; Murphy SA; Charlesworth A; Braunwauld E; Langer A
    Am Heart J; 2005 Feb; 149(2):275-83. PubMed ID: 15846265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive versus conservative strategies in unstable angina and non-Q-wave myocardial infarction following treatment with tirofiban: rationale and study design of the international TACTICS-TIMI 18 Trial. Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy. Thrombolysis In Myocardial Infarction.
    Cannon CP; Weintraub WS; Demopoulos LA; Robertson DH; Gormley GJ; Braunwald E
    Am J Cardiol; 1998 Sep; 82(6):731-6. PubMed ID: 9761082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ST-segment deviation on the admission electrocardiogram, treatment strategy, and outcome in non-ST-elevation acute coronary syndromes A substudy of the Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) Trial.
    Windhausen F; Hirsch A; Tijssen JG; Cornel JH; Verheugt FW; Klees MI; de Winter RJ;
    J Electrocardiol; 2007; 40(5):408-15. PubMed ID: 17604045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early invasive strategy improves outcomes in patients with acute coronary syndrome with previous coronary artery bypass graft surgery: a report from TACTICS-TIMI 18.
    Kugelmass AD; Sadanandan S; Lakkis N; Dibattiste PM; Robertson DH; Demopoulos LA; Gibson CM; Weintraub WS; Murphy SA; Cannon CP;
    Crit Pathw Cardiol; 2006 Sep; 5(3):167-72. PubMed ID: 18340233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of different patterns of invasive care on quality of life outcomes in patients with non-ST elevation acute coronary syndrome: results from the GUSTO-IIb Canada-United States substudy.
    Kaul P; Armstrong PW; Fu Y; Knight JD; Clapp-Channing NE; Sutherland W; Granger CB; Mark DB;
    Can J Cardiol; 2004 Jun; 20(8):760-6. PubMed ID: 15229756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical characteristics, in-hospital outcomes and predictors of in-hospital mortality in patients with acute coronary syndromes without persistent ST-segment elevation assigned to early invasive treatment strategy].
    Szyguła-Jurkiewicz B; Wojnicz R; Trzeciak P; Niklewski T; Zembala M; Poloński L
    Przegl Lek; 2005; 62(5):265-9. PubMed ID: 16334529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal timing of intervention in non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Registry.
    Ryan JW; Peterson ED; Chen AY; Roe MT; Ohman EM; Cannon CP; Berger PB; Saucedo JF; DeLong ER; Normand SL; Pollack CV; Cohen DJ;
    Circulation; 2005 Nov; 112(20):3049-57. PubMed ID: 16275863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of quantitative troponin T measurements in unstable angina/non-ST-segment elevation acute myocardial infarction treated early and predominantly with percutaneous coronary intervention.
    Mueller C; Neumann FJ; Perruchoud AP; Zeller T; Buettner HJ
    Am J Med; 2004 Dec; 117(12):897-902. PubMed ID: 15629727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
    Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with failure of medical therapy in patients with unstable angina and non-Q wave myocardial infarction. A TIMI-IIIB database study.
    Stone PH; Thompson B; Zaret BL; Chaitman B; Gibson RS; Schweiger MJ; Steingart R; Kirshenbaum J; Thompson C; Fung A; McCabe CH; Knatterud GL; Braunwald E
    Eur Heart J; 1999 Aug; 20(15):1084-93. PubMed ID: 10413638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis.
    O'Donoghue M; Antman EM; Braunwald E; Murphy SA; Steg PG; Finkelstein A; Penny WF; Fridrich V; McCabe CH; Sabatine MS; Wiviott SD
    J Am Coll Cardiol; 2009 Aug; 54(8):678-85. PubMed ID: 19679245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic therapy with fondaparinux in relation to interventional management strategy in patients with ST- and non-ST-segment elevation acute coronary syndromes: an individual patient-level combined analysis of the Fifth and Sixth Organization to Assess Strategies in Ischemic Syndromes (OASIS 5 and 6) randomized trials.
    Mehta SR; Boden WE; Eikelboom JW; Flather M; Steg PG; Avezum A; Afzal R; Piegas LS; Faxon DP; Widimsky P; Budaj A; Chrolavicius S; Rupprecht HJ; Jolly S; Granger CB; Fox KA; Bassand JP; Yusuf S;
    Circulation; 2008 Nov; 118(20):2038-46. PubMed ID: 18955665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognosis after acute coronary syndrome. Lack of difference according to the sex].
    Bounhoure JP; Farah B; Fajadet J; Marco J
    Bull Acad Natl Med; 2004; 188(3):383-97; discussion 397-9. PubMed ID: 15584651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.